Steven Heylen: Hydrolyzed Collagen Injections for Knee Osteoarthritis as a New Treatment Option
Steven Heylen, Orthopaedic surgeon, Knee and Shoulder Surgeon at OrthoClinic Lier, shared a post on LinkedIn about a recent article by Angel Alberto Heredia Sulbaran and Pablo Alonso Gomez, published in BMC Musculoskeletal Disorders, adding:
“Injectables for knee OA … New place for hydrolysed collagen injections in my treatment protocol
Intra-articular injections of low-molecular-weight hydrolyzed collagen
This patient (admittedly n=1) had no positive effect of hyaluronic acid injections for patellofemoral OA.
Patient had a hematological contraindication for PRP treatment. After 3 hydrolysed collagen peptide injections, the pain improved by 70% now 3 months out from the last injection.
Collagen peptides are hypothesized “to provide structural reinforcement to the extracellular matrix and stimulate proregenerative cellular activity”.
As great as that sounds… scientific evidence however is scarce…
Randomized controlled trials remain very limited, but the safety profile has shown a low incidence of adverse immunogenic or inflammatory reactions.
These collagen injections in my practice offer a valuable alternative (biologic?) therapy for patients in whom platelet-rich plasma (PRP) is contraindicated and hyaluronic acid injections failed to provide enough improvement in symptoms.
I’ve had some pretty good results so far.
We need further clinical validation though!
I’m keeping patient data to report on later in time …
I’m very interested what some of the brightest minds in orthobiologics think about this?
‘Pro-regenerative’ or a lot of hot air?”
Title: Efficacy of hydrolyzed collagen injections compared to platelet-rich plasma and hyaluronic acid in the treatment of patients with symptomatic knee osteoarthritis: a retrospective clinical study
Authors: Angel Alberto Heredia Sulbaran, Pablo Alonso Gomez
See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery